FDA Clearance Tracker · K243858
TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge
Last checked: Nov 20, 2026Latest source record: Jan 15, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jan 15, 2025
Substantially Equivalent
Time to decision
30 days
Received Dec 16, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K243858
- Device name
- TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge
- Applicant
- Haemonetics Corporation
- Applicant location
- Boston, MA
- Received
- Dec 16, 2024
- Decided
- Jan 15, 2025
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 864.5425
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JPA. The earliest in FDA's data is K760594, decided Nov 24, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243858
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Haemonetics Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232018 · Decided Mar 29, 2024 · 266 days after receipt
Device type: System, Multipurpose For In Vitro Coagulation Studies (JPA) · Laboratory Medicine & Pathology
K221722 · Decided Nov 15, 2022 · 154 days after receipt
Device type: Apparatus, Autotransfusion (CAC) · Anesthesiology & Respiratory
K183160 · Decided May 9, 2019 · 175 days after receipt
Device type: System, Multipurpose For In Vitro Coagulation Studies (JPA) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.